🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉 🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉
Aussie firm initiates bronchitis drug trial for smokers

Singapore: Australia-based clinical-stage drug development company, Invion, initiated and commenced patient enrolment in...

July 23, 2013 | Tuesday | News
Breast cancer boasts of highest drug pipeline'

Singapore: Breast cancer therapeutics pipeline has higher innovation in first-in-class molecules, with many new technolo...

September 8, 2014 | Monday | News
Ascend to begin PhII trial for skin cancer

Singapore: Ascend Biopharmaceuticals, a Melbourne-based immunotherapy company, plans to begin a Phase 2 clinical trial o...

September 11, 2014 | Thursday | News
Singapore firm progresses on urinary tract infections drug

Singapore: Singapore's biopharmaceutical company, MerLion Pharmaceuticals, has recieved positive results from a phase 2 ...

January 9, 2015 | Friday | News
US investment firm expands in China

Singapore: Ally Bridge Group (ABG), a global healthcare-focused investment platform, has expanded its global biopharmace...

January 9, 2015 | Friday | News
Aspirin may reduce ovarian cancer risk: NIH

Singapore: Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by s...

February 7, 2014 | Friday | Analysis
Zebrafish genes linked to human respiratory diseases'

Singapore: A small freshwater fish found in many tropical aquariums may hold the key to unlocking one of the leading cau...

September 22, 2014 | Monday | News
FDA to further review Otsuka kidney drug

Singapore: Otsuka Pharmaceutical received a Complete Response Letter (CRL) from the US FDA regarding the new drug applic...

September 2, 2013 | Monday | News
Satish Jindal, BMS India R&D head, to lead US innovation venture

Singapore: Allied-Bristol Life Sciences, a jointly owned enterprise between Allied Minds and Bristol-Myers Squibb, has a...

October 3, 2014 | Friday | News
US firm discovers potential biomarker for malaria

Singapore: US based biotech firm, Genocea Biosciences, has identified a cluster of antigens, generated using its ATLAS a...

November 11, 2014 | Tuesday | News
Malaria drug may cure asthma: Research

Singapore: National University of Singapore has demonstrated effectiveness of artesunate, a common herbal-based anti-mal...

August 4, 2014 | Monday | News
Danish firm, Aussie instiute to co-develop pathological drugs

Singapore: Danish firm, Mirrx Therapeutics and Australia's Centenary Institute of Cancer Medicine and Cell Biology has f...

November 8, 2013 | Friday | News
Dainippon sets up cancer drug subsidiary in the US

Singapore: Japan-based Dainippon Sumitomo Pharma (DSP), has decided to establish an anti-cancer drugs sales company in t...

October 10, 2013 | Thursday | News
Japanese, Korean firm to jointly develop breast cancer drug

Singapore: Japanese company, Kyowa Hakko Kirin and Korean firm, Syndax Pharmaceuticals, have entered into a license agre...

January 8, 2015 | Thursday | News
Novogen's chemotherapeutic agent set to enter human trial in 2015

Singapore: Cantrixil, a first-in-class experimental chemotherapeutic, developed by Australia/US-based biotech firm Novog...

December 16, 2014 | Tuesday | News
Auspherix raises $1 mn for antibiotics

Singapore: Auspherix, an early stage anti-infectives company developing novel antibiotics to treat resistant bacterial d...

October 23, 2014 | Thursday | News
Clinuvel's subisidiary develops drug candidate for vitiligo

Singapore: Australia and Switzerland based Clinuvel Pharmaceuticals' Singapore subsidiary Vallaurix has successfully com...

May 6, 2015 | Wednesday | News
EU supports Pyridorin drug trial for diabetic nephropathy

Singapore: NephroGenex, pharmaceutical company focused on the development of therapeutics to treat kidney disease, has r...

January 9, 2015 | Friday | News